Hunan G-Med Pharmaceutical

Hunan G-Med Pharmaceutical is a China-based pharmaceutical company focused on the research, development, and large-scale production of high-end generic drugs and innovative chemical medicines. Established in 2015 and headquartered in Changsha, the company operates a modern manufacturing base that complies with global GMP standards. Its core therapeutic focus includes cardiovascular diseases, metabolic disorders, and anti-infectives, with a portfolio featuring sustained-release formulations and complex generics. G-Med is designated as a National High-tech Enterprise, emphasizing its commitment to technological innovation in drug delivery systems. The company aims to provide high-quality, affordable healthcare solutions to the domestic and international markets.